Abclon Derives Clinical Materials for CAR-T Treatment of Ovarian Cancer
April 21, 2020 6:00 pmBy Shim Hyun-tai
Antibody-based therapeutics developer Abclon said Tuesday that it has successfully drawn final candidates for the clinical trials of the next-generation chimeric antigen receptor T (CAR-T) cell therapy for ovarian cancer.
Abclon plans to enter clinical trials in … Read more